你即將離開本站

並前往https://www.cancer.gov/news-events/cancer-currents-blog/2017/neratinib-breast-cancer-fda

Neratinib Approved by FDA for HER2-Positive Breast Cancer

Neratinib (Nerlynx) has been approved by FDA for patients with early-stage HER2-positive breast cancer who have finished at least 1 year of ...

確定！ 回上一頁

查詢 「Neratinib」的人也找了：

  1. neratinib中文
    2.
  2. neratinib台灣
    3.
  3. neratinib藥廠
    4.
  4. neratinib健保
    5.
  5. neratinib乳癌
    6.
  6. 乳癌治療指引2020
    7.
  7. neratinib副作用
    8.
  8. nerlynx中文
    9.